There is a sharp increase in India's cancer cases with only 20% - 30% of cancers are being diagnosed in stages I and II.
Fortunately, PET-CT has revolutionized cancer diagnosis. However, PET-CT requires a radiopharmaceutical (FDG) to function, which is extremely short-lived and requires an expensive cyclotron. Our vision is to make FDG accessible and affordable to most of the PET-CT facilities in India.
Increase Affordability of FDG
Increase Accessibility of FDG
Society + Science
Create Employment + Facilitate Research
Are you an investor?
We're passionate about empowering our patients and practitioners. If you would like to know more about the project then please contact firstname.lastname@example.org.
Thank you! We will be in touch with you.
Something went wrong! Please try again